|1.||Neznamov, G G: 4 articles (01/2012 - 07/2008)|
|2.||Siuniakov, S A: 4 articles (01/2012 - 07/2008)|
|3.||Reutova, M A: 3 articles (01/2012 - 01/2009)|
|4.||Seredenin, S B: 3 articles (11/2011 - 05/2009)|
|5.||Bochkarev, V K: 2 articles (01/2012 - 07/2008)|
|6.||Durnev, A D: 2 articles (11/2011 - 01/2011)|
|7.||Kovalenko, L P: 2 articles (11/2011 - 01/2011)|
|8.||Tallerova, A V: 2 articles (11/2011 - 01/2011)|
|9.||Siuniakov, T S: 2 articles (01/2011 - 01/2009)|
|10.||Dorofeeva, O A: 2 articles (01/2011 - 01/2009)|
01/01/2009 - "An aim of a randomized blind study was to assess therapeutic efficacy and safety of ladasten used as an antiastenic drug in patients with neurasthenia. "
01/01/2012 - "The study was focused on the clinico-pharmacological analysis of differences between subjective and objective assessment of the effects of antiasthenic drug ladasten and placebo effects in patients with neurasthenia with different individual patterns manifested in their EEG alpha rhythms and MMPI findings. "
01/01/2009 - "[Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)]."
01/01/2012 - "It is established that, in patients with neurasthenia characterized by reduced EEG alpha activity combined with emotional lability and inertness, the therapeutic action and effectiveness of ladasten and placebo was more robust (the subjective estimation was higher) than in patients with prominent alpha rhythm and sthenic personal traits. "
01/01/2012 - "[Ladasten versus placebo effect self-evaluated by neurasthenia patients with different EEG alpha rhythm types]."
|5.||Dystonia (Limb Dystonia)
|2.||S 20098 (agomelatine)